for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

RaySearch Laboratories AB (publ)

RAYb.ST

Latest Trade

163.40SEK

Change

-0.90(-0.55%)

Volume

39,905

Today's Range

161.70

 - 

165.30

52 Week Range

82.35

 - 

193.00

As of on the Stockholm Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Raysearch Gets New Regulatory Clearance For RayStation In China

Oct 4 (Reuters) - RaySearch Laboratories AB (publ) <RAYb.ST>::HAS RECEIVED NEW REGULATORY CLEARANCE FOR RAYSTATION IN CHINA.WITH THIS CLEARANCE RAYSEARCH CAN CONTINUE TO SUPPLY INNOVATIVE AND MACHINE AGNOSTIC RAYSTATION TO CUSTOMERS IN CHINA..RECEIVED A NEW REGULATORY CLEARANCE FROM CHINESE AUTHORITIES NMPA (PREVIOUSLY CFDA) FOR TREATMENT PLANNING SYSTEM RAYSTATION.

RaySearch Awarded Supply Agreement With US Department Of Veterans Affairs

Oct 1 (Reuters) - RaySearch Laboratories AB (publ) <RAYb.ST>::RAYSEARCH AWARDED SUPPLY AGREEMENT WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.TO BECOME ONE OF AGENCY'S PREFERRED PROVIDERS OF RADIATION THERAPY SOFTWARE TO HOSPITALS WITHIN VETERANS HEALTH ADMINISTRATION.

RaySearch Expands To New Market With Distribution Agreement For Russia

Sept 26 (Reuters) - RaySearch Laboratories AB (publ) <RAYb.ST>::EXPANDS TO A NEW MAJOR MARKET WITH DISTRIBUTION AGREEMENT FOR RUSSIA.ENTERED INTO A LONG-TERM DISTRIBUTION AGREEMENT WITH HEALTHCARE INDUSTRY DISTRIBUTION COMPANY MEDEQI IN RUSSIA.CONTINUES ITS GLOBAL EXPANSION WITH THIS DISTRIBUTOR AGREEMENT IN RUSSIA, WHICH IS A NEW MARKET FOR RAYSEARCH.

RaySearch Q2 Operating Profit Rises To SEK 28.8 Mln

Aug 20 (Reuters) - RaySearch Laboratories AB (publ) <RAYb.ST>::INTERIM REPORT JANUARY - JUNE 2019.Q2 OPERATING PROFIT SEK 28.8 M (26.2).Q2 NET SALES SEK 189.7 MILLION VERSUS SEK 141.0 MILLION YEAR AGO.Q2 PROFIT AFTER TAX SEK 21.8 M (20.6).Q2 ORDER INTAKE SEK 370.6 M (206.2),.GOAL IS THAT CONTINUING DIALOG WITH CANCER CENTERS WILL GENERATE EVEN MORE POSITIVE FINANCIAL RESULTS IN H2 2019.

Raysearch And Mevion Extend Collaboration

July 24 (Reuters) - RaySearch Laboratories AB (publ) <RAYb.ST>::AND MEVION EXTEND COLLABORATION TO SUPPORT ADVANCED HYPERSCAN TREATMENT PLANNING CAPABILITIES.THIS COLLABORATION ALSO INCLUDES AN ORDER FROM MEVION ON RAYSTATION LICENSES WITH TOTAL AMOUNT OF 4 MUSD, OF WHICH APPROXIMATELY 0.9 MUSD IS RECOGNIZED AS REVENUE WITHIN Q2 OF 2019.MAJORITY OF REMAINING ORDER VALUE IS EXPECTED TO BE RECOGNIZED FOR REVENUE OVER NEXT 18 MONTHS..STRENGTHENING STRATEGIC COLLABORATION EFFORT TO FURTHER ADVANCE CAPABILITIES WITH MEVION'S HYPERSCAN PROTON THERAPY SYSTEM.

RaySearch Laboratories Signs Multi-System Agreement With Swiss Medical Network

July 18 (Reuters) - RaySearch Laboratories AB (publ) <RAYb.ST>::SWISS MEDICAL NETWORK ADVANCES CANCER CARE IN SWITZERLAND WITH MULTI-SYSTEM AGREEMENT FOR ACCURAY RADIATION THERAPY SYSTEMS AND RAYSEARCH ONCOLOGY SOFTWARE SYSTEMS.FIRST PATIENT TREATMENTS USING COMBINATION OF RADIXACT SYSTEM AND RAYSTATION BY SWISS MEDICAL NETWORK ARE ANTICIPATED TO TAKE PLACE IN 2020.

Raysearch And Vision RT Announce Strategic Partnership

July 14 (Reuters) - RaySearch Laboratories AB (publ) <RAYb.ST>::RAYSEARCH AND VISION RT ANNOUNCE STRATEGIC PARTNERSHIP.RAYSEARCH -STRATEGIC PARTNERSHIP TO WORK TOGETHER ON TECHNOLOGY DEVELOPMENT; PROJECTS DETAILS OF THESE DEVELOPMENTS ARE CURRENTLY CONFIDENTIAL.

RaySearch Gets Order Worth About USD 2.3 Mln

July 11 (Reuters) - RaySearch Laboratories AB (publ) <RAYb.ST>::LEADING US PROTON CENTER SELECTS RAYSTATION FOR TREATMENT PLANNING.TOTAL ORDER VALUE EXCLUDING SERVICE AGREEMENT IS ABOUT USD 2.3 MILLION, MOST OF WHICH RECOGNIZED AS REVENUE WITHIN Q2 2019.

RaySearch Gets Order From Moffitt Cancer Center in Florida

July 9 (Reuters) - RaySearch Laboratories AB (publ) <RAYb.ST>::MOFFITT CANCER CENTER SELECTS RAYSTATION FOR TREATMENT PLANNING.MOFFITT CANCER CENTER WILL IMPLEMENT RAYSEARCH'S ADVANCED TECHNOLOGIES IN DEPARTMENT OF RADIATION ONCOLOGY..

RaySearch Receives Order MedAustron

June 28 (Reuters) - RaySearch Laboratories AB (publ) <RAYb.ST>::RECEIVES LARGEST ORDER TO DATE: MEDAUSTRON CHOOSES RAYSTATION, RAYCARE AND RAYCOMMAND FOR TWO PROTON AND CARBON ION TREATMENT FACILITIES.COMBINED ORDER VALUE IS ABOUT 12 MEUR.ORDER, WHICH IS SINGLE LARGEST TO DATE FOR RAYSEARCH, WILL PROVIDE A COMPREHENSIVE SETUP TO EBG MEDAUSTRON GMBH AND MEDAUSTRON INTERNATIONAL GMBH FACILITIES.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up